October 2013

Gliptins in the Treatment of Type 2 Diabetes Mellitus

October 01, 2013

Diabetes

Aparna M. Bhagavat, MD, FACC, says gliptins have a promising role in the control of type 2 diabetes, as they decrease A1C without hypoglycemia, weight gain, or any obvious adverse effects on cardiovascular outcomes.

A New Pulmonary Arterial Hypertension Drug on the Horizon

October 01, 2013

CME Reviews

In pulmonary arterial hypertension patients, riociguat serves as a reasonable first-line alternative to PDE-5 inhibitors or in combination therapy with an endothelin antagonist or inhaled prostacyclin analogues.

Geographic Variation in Procedure Use Among Medicare Recipients

October 01, 2013

CME Reviews

The wide variation in geographic utilization of coronary angiography, percutaneous coronary intervention (PCI), and coronary artery bypass graft (CABG) surgery, despite reimbursement structure, suggests that capitation alone may not lead to reductions in variation.